These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 8842441

  • 1. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
    Wilson JL, Nayanar V, Walker JS.
    Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
    [Abstract] [Full Text] [Related]

  • 2. Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis.
    Binder W, Walker JS.
    Br J Pharmacol; 1998 Jun; 124(4):647-54. PubMed ID: 9690855
    [Abstract] [Full Text] [Related]

  • 3. Anti-inflammatory effects of contralateral administration of the kappa-opioid agonist U-50,488H in rats with unilaterally induced adjuvant arthritis.
    Bileviciute-Ljungar I, Saxne T, Spetea M.
    Rheumatology (Oxford); 2006 Mar; 45(3):295-302. PubMed ID: 16249243
    [Abstract] [Full Text] [Related]

  • 4. Anti-inflammatory effects of kappa-opioids in adjuvant arthritis.
    Walker JS, Howlett CR, Nayanar V.
    Life Sci; 1995 Mar; 57(4):371-8. PubMed ID: 7603309
    [Abstract] [Full Text] [Related]

  • 5. Contralateral but not systemic administration of the kappa-opioid agonist U-50,488H induces anti-nociception in acute hindpaw inflammation in rats.
    Bileviciute-Ljungar I, Spetea M.
    Br J Pharmacol; 2001 Jan; 132(1):252-8. PubMed ID: 11156584
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
    Pugsley MK, Penz WP, Walker MJ, Wong TM.
    Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979
    [Abstract] [Full Text] [Related]

  • 7. Chronic kappa opioid receptor antagonism produces supersensitivity to U-50,488H at the hypothalamo-pituitary-adrenocortical (HPA) axis level.
    Alcaraz C, Milanés MV, Vargas ML.
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1385-9. PubMed ID: 8396634
    [Abstract] [Full Text] [Related]

  • 8. Behavioural effect of pretreatment with opioid antagonists and sigma binding site ligands on the abnormal motor response produced by the kappa opioid agonist U50,488H in guinea pigs.
    Brent PJ.
    Neuropharmacology; 1993 Aug; 32(8):751-60. PubMed ID: 8413839
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative hypotensive actions of three nonpeptide kappa opioid agonists on hippocampus of SHRs and normotensive WKY rats.
    Zhai QZ, Ingenito AJ.
    J Cardiovasc Pharmacol; 1998 Jun; 31(6):806-12. PubMed ID: 9641463
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U-50,488H against noxious thermal, mechanical and inflammatory stimuli.
    Idänpään-Heikkilä JJ, Kalso EA, Seppälä T.
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1306-13. PubMed ID: 7996439
    [Abstract] [Full Text] [Related]

  • 15. Effects of U-50,488H, a kappa-opioid receptor agonist, on the learned helplessness model of depression in mice.
    Ukai M, Suzuki M, Mamiya T.
    J Neural Transm (Vienna); 2002 Sep; 109(9):1221-5. PubMed ID: 12203050
    [Abstract] [Full Text] [Related]

  • 16. An electrophysiological basis for the antiarrhythmic actions of the kappa-opioid receptor agonist U-50,488H.
    Pugsley MK, Saint DA, Walker MJ.
    Eur J Pharmacol; 1994 Aug 22; 261(3):303-9. PubMed ID: 7813552
    [Abstract] [Full Text] [Related]

  • 17. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
    Bhargava HN, Gulati A, Ramarao P.
    J Pharmacol Exp Ther; 1989 Oct 22; 251(1):21-6. PubMed ID: 2552075
    [Abstract] [Full Text] [Related]

  • 18. Kappa opioid receptor agonists suppress absence seizures in WAG/Rij rats.
    Przewłocka B, Lasoń W, Machelska H, van Luijtelaar G, Coenen A, Przewłocki R.
    Neurosci Lett; 1995 Feb 17; 186(2-3):131-4. PubMed ID: 7777181
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Withdrawal contractures of guinea-pig isolated ileum after acute activation of kappa-opioid receptors.
    Morrone LA, Romanelli L, Amico MC, Valeri P.
    Br J Pharmacol; 1993 May 17; 109(1):48-52. PubMed ID: 8388301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.